[HTML][HTML] Human trials exploring anti-aging medicines
L Guarente, DA Sinclair, G Kroemer - Cell Metabolism, 2024 - cell.com
Here, we summarize the current knowledge on eight promising drugs and natural
compounds that have been tested in the clinic: metformin, NAD+ precursors, glucagon-like …
compounds that have been tested in the clinic: metformin, NAD+ precursors, glucagon-like …
Aging of mesenchymal stem cell: machinery, markers, and strategies of fighting
Human mesenchymal stem cells (MSCs) are primary multipotent cells capable of
differentiating into osteocytes, chondrocytes, and adipocytes when stimulated under …
differentiating into osteocytes, chondrocytes, and adipocytes when stimulated under …
The senescence-associated secretory phenotype and its physiological and pathological implications
Cellular senescence is a state of terminal growth arrest associated with the upregulation of
different cell cycle inhibitors, mainly p16 and p21, structural and metabolic alterations …
different cell cycle inhibitors, mainly p16 and p21, structural and metabolic alterations …
[HTML][HTML] Major depression and the biological hallmarks of aging
Major depressive disorder (MDD) is characterized by psychological and physiological
manifestations contributing to the disease severity and outcome. In recent years, several …
manifestations contributing to the disease severity and outcome. In recent years, several …
Cancer-related accelerated ageing and biobehavioural modifiers: a framework for research and clinical care
A growing body of evidence indicates that patients with cancer who receive cytotoxic
treatments (such as chemotherapy or radiotherapy) have an increased risk of accelerated …
treatments (such as chemotherapy or radiotherapy) have an increased risk of accelerated …
Immune system and sarcopenia: Presented relationship and future perspective
X Zhang, H Li, M He, J Wang, Y Wu, Y Li - Experimental Gerontology, 2022 - Elsevier
Sarcopenia, a geriatric syndrome that is characterized by a progressive and generalized
skeletal muscle disorder, can be associated with many comorbidities, including obesity …
skeletal muscle disorder, can be associated with many comorbidities, including obesity …
Senescent cells: a therapeutic target in cardiovascular diseases
M Suda, KH Paul, T Minamino, JD Miller, A Lerman… - Cells, 2023 - mdpi.com
Senescent cell accumulation has been observed in age-associated diseases including
cardiovascular diseases. Senescent cells lack proliferative capacity and secrete senescence …
cardiovascular diseases. Senescent cells lack proliferative capacity and secrete senescence …
Senescence and the tumor-immune landscape: Implications for cancer immunotherapy
L Chibaya, J Snyder, M Ruscetti - Seminars in cancer biology, 2022 - Elsevier
Cancer therapies, including conventional chemotherapy, radiation, and molecularly targeted
agents, can lead to tumor eradication through a variety of mechanisms. In addition to their …
agents, can lead to tumor eradication through a variety of mechanisms. In addition to their …
[HTML][HTML] p21 induces a senescence program and skeletal muscle dysfunction
DA Englund, A Jolliffe, Z Aversa, X Zhang… - Molecular …, 2023 - Elsevier
Recent work has established associations between elevated p21, the accumulation of
senescent cells, and skeletal muscle dysfunction in mice and humans. Using a mouse …
senescent cells, and skeletal muscle dysfunction in mice and humans. Using a mouse …
[HTML][HTML] Targeting cellular senescence in metabolic disease
AK Palmer, T Tchkonia, JL Kirkland - Molecular Metabolism, 2022 - Elsevier
Cellular senescence is a cell fate involving cell cycle arrest, resistance against apoptosis,
and the development of a secretome that can be pro-inflammatory. In aging and obesity …
and the development of a secretome that can be pro-inflammatory. In aging and obesity …